Ørstavik Ragnhild E, Haugeberg Glenn, Mowinckel Petter, Høiseth Arne, Uhlig Till, Falch Jan A, Halse Johan I, McCloskey Eugene, Kvien Tore K
Oslo City Department of Rheumatology, Oslo, Norway.
Arch Intern Med. 2004 Feb 23;164(4):420-5. doi: 10.1001/archinte.164.4.420.
Previous studies have shown an increased prevalence of osteoporosis in rheumatoid arthritis (RA), but the extent of osteoporotic fractures is not clarified. The aim of this study was to compare the prevalence of vertebral deformities in a representative, population-based cohort of female patients with RA with that in matched controls, and to examine the relationship between deformities and RA, bone mineral density (BMD), and corticosteroid use.
Female patients (mean age, 63.0 years; range, 50.7-73.6 years) were recruited from a county register of patients with RA. Population controls were matched for age, sex, and residential area. Participants had thoracolumbar radiographs taken according to a standardized procedure, and BMD was measured at the hip and spine (L2-L4).
The overall number of vertebral deformities was substantially higher in the RA group compared with controls (147 vs 51, applying the morphometric criteria), with a highly significant difference between patients and controls regarding the presence of multiple deformities measured morphometrically (11.2% vs 4.8%; odds ratio, 2.60; 95% confidence interval, 1.21-6.04) and moderate or severe deformities measured semiquantitatively (17.3% vs 10.0%; odds ratio, 2.00; 95% confidence interval, 1.11-3.74). In Poisson regression analysis, vertebral deformities were independently associated with RA, BMD, and long-term corticosteroid use.
Vertebral deformities are markedly increased in patients with RA compared with controls, especially regarding severe and multiple deformities. A diagnosis of RA was associated with vertebral deformities independently of BMD and long-term corticosteroid use. These findings have important implications for prevention of established osteoporosis in RA.
既往研究显示类风湿关节炎(RA)患者骨质疏松患病率增加,但骨质疏松性骨折的程度尚不清楚。本研究旨在比较具有代表性的、基于人群的女性RA患者队列与匹配对照中椎体畸形的患病率,并探讨畸形与RA、骨密度(BMD)及皮质类固醇使用之间的关系。
从一个县的RA患者登记册中招募女性患者(平均年龄63.0岁;范围50.7 - 73.6岁)。人群对照在年龄、性别和居住地区方面进行匹配。参与者按照标准化程序拍摄胸腰椎X线片,并测量髋部和脊柱(L2 - L4)的骨密度。
与对照组相比,RA组椎体畸形的总数显著更高(根据形态学标准分别为147例和51例),在通过形态学测量存在多个畸形方面(11.2%对4.8%;优势比,2.60;95%置信区间,1.21 - 6.04)以及通过半定量测量存在中度或重度畸形方面(17.3%对10.0%;优势比,2.00;95%置信区间,1.11 - 3.74),患者与对照之间存在高度显著差异。在泊松回归分析中,椎体畸形与RA、BMD及长期使用皮质类固醇独立相关。
与对照组相比,RA患者的椎体畸形明显增加,尤其是严重和多个畸形。RA的诊断与椎体畸形独立相关,与BMD和长期使用皮质类固醇无关。这些发现对预防RA患者已有的骨质疏松具有重要意义。